XML 45 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Valuation (Tables)
3 Months Ended
Mar. 31, 2018
Fair Value Disclosures [Abstract]  
Schedule Of Financial Instruments
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at March 31, 2018:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
(In thousands)
Assets:
 
 
 
 
 
 
 
 
Cash equivalents
 
$
1,348

 
$

 
$

 
$
1,348

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
1,115,438

 
$
6,128

 
$
1,121,566

U.S. Treasury securities
 

 
2,200

 

 
2,200

Private label residential mortgage-backed securities
 

 
177,114

 
111,862

 
288,976

Private label commercial mortgage-backed securities
 

 
19,457

 
13,709

 
33,166

Commercial mortgage loans
 

 

 
109,294

 
109,294

Residential mortgage loans
 

 

 
240,781

 
240,781

Collateralized loan obligations
 

 
199,677

 
27,479

 
227,156

Consumer loans and asset-backed securities backed by consumer loans
 

 

 
148,422

 
148,422

Corporate debt
 

 
74,198

 
18,000

 
92,198

Real estate owned
 

 

 
29,110

 
29,110

Corporate equity investments
 

 

 
50,869

 
50,869

Total investments, at fair value
 

 
1,588,084

 
755,654

 
2,343,738

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 

 

 
3,069

 
3,069

Credit default swaps on corporate bond indices
 

 
1,143

 

 
1,143

Credit default swaps on corporate bonds
 

 
5,999

 

 
5,999

Credit default swaps on asset-backed indices
 

 
4,269

 

 
4,269

Interest rate swaps
 

 
15,532

 

 
15,532

Total return swaps
 

 
18

 

 
18

Forwards
 

 
8

 

 
8

Total financial derivatives–assets, at fair value
 

 
26,969

 
3,069

 
30,038

Repurchase agreements, at fair value
 

 
132,538

 

 
132,538

Total investments, financial derivatives–assets, and repurchase agreements, at fair value
 
$

 
$
1,747,591

 
$
758,723

 
$
2,506,314

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(499,620
)
 
$

 
$
(499,620
)
Government debt
 

 
(107,156
)
 

 
(107,156
)
Corporate debt
 

 
(46,944
)
 

 
(46,944
)
Common stock
 
(38,242
)
 

 

 
(38,242
)
Total investments sold short, at fair value
 
(38,242
)
 
(653,720
)
 

 
(691,962
)
 
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 
$

 
$
(9,679
)
 
$

 
$
(9,679
)
Credit default swaps on corporate bonds
 

 
(14,772
)
 

 
(14,772
)
Credit default swaps on asset-backed indices
 

 
(2,200
)
 

 
(2,200
)
Interest rate swaps
 

 
(7,153
)
 

 
(7,153
)
Total return swaps
 

 
(1
)
 

 
(1
)
Futures
 
(1,023
)
 

 

 
(1,023
)
Forwards
 

 
(97
)
 

 
(97
)
Total financial derivatives–liabilities, at fair value
 
(1,023
)
 
(33,902
)
 

 
(34,925
)
Other secured borrowings, at fair value
 

 

 
(113,775
)
 
(113,775
)
Total investments sold short, financial derivatives–liabilities, and other secured borrowings, at fair value
 
$
(39,265
)
 
$
(687,622
)
 
$
(113,775
)
 
$
(840,662
)

The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2017:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
(In thousands)
Assets:
 
 
 
 
 
 
 
 
Cash equivalents
 
$
26,500

 
$

 
$

 
$
26,500

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
989,341

 
$
6,173

 
$
995,514

Private label residential mortgage-backed securities
 

 
158,369

 
101,297

 
259,666

Private label commercial mortgage-backed securities
 

 
28,398

 
12,347

 
40,745

Commercial mortgage loans
 

 

 
108,301

 
108,301

Residential mortgage loans
 

 

 
182,472

 
182,472

Collateralized loan obligations
 

 
185,905

 
24,911

 
210,816

Consumer loans and asset-backed securities backed by consumer loans
 

 

 
135,258

 
135,258

Corporate debt
 

 
51,246

 
23,947

 
75,193

Real estate owned
 

 

 
26,277

 
26,277

Corporate equity investments
 

 

 
37,465

 
37,465

Total investments, at fair value
 

 
1,413,259

 
658,448

 
2,071,707

 
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 
$

 
$

 
$
3,140

 
$
3,140

Credit default swaps on corporate bond indices
 

 
1,429

 

 
1,429

Credit default swaps on corporate bonds
 

 
8,888

 

 
8,888

Credit default swaps on asset-backed indices
 

 
5,393

 

 
5,393

Interest rate swaps
 

 
9,266

 

 
9,266

Options
 
3

 
1

 

 
4

Futures
 
45

 

 

 
45

Total financial derivatives–assets, at fair value
 
48

 
24,977

 
3,140

 
28,165

Repurchase agreements, at fair value
 

 
155,949

 

 
155,949

Total investments, financial derivatives–assets, and repurchase agreements, at fair value
 
$
48

 
$
1,594,185

 
$
661,588

 
$
2,255,821

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(460,189
)
 
$

 
$
(460,189
)
Government debt
 

 
(90,149
)
 

 
(90,149
)
Corporate debt
 

 
(55,211
)
 

 
(55,211
)
Common stock
 
(36,691
)
 

 

 
(36,691
)
Total investments sold short, at fair value
 
(36,691
)
 
(605,549
)
 

 
(642,240
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(12,367
)
 

 
(12,367
)
Credit default swaps on corporate bonds
 

 
(15,930
)
 

 
(15,930
)
Credit default swaps on asset-backed indices
 

 
(980
)
 

 
(980
)
Interest rate swaps
 

 
(6,015
)
 

 
(6,015
)
Futures
 
(508
)
 

 

 
(508
)
Forwards
 

 
(473
)
 

 
(473
)
Total financial derivatives–liabilities, at fair value
 
(508
)
 
(35,765
)
 

 
(36,273
)
Other secured borrowings, at fair value
 

 

 
(125,105
)
 
(125,105
)
Total investments sold short, financial derivatives–liabilities, and other secured borrowings, at fair value
 
$
(37,199
)
 
$
(641,314
)
 
$
(125,105
)
 
$
(803,618
)
Schedule Of Significant Unobservable Inputs, Qualitative Information
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2017:
 
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
 
$
40,870

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
45.00

 
$
183.00

 
$
81.63

Collateralized loan obligations
 
10,288

 
Market Quotes
 
Non Binding Third-Party Valuation
 
85.00

 
435.00

 
138.94

Corporate debt and non-exchange traded corporate equity
 
6,797

 
Market Quotes
 
Non Binding Third-Party Valuation
 
8.88

 
105.63

 
82.94

Private label commercial mortgage-backed securities
 
7,577

 
Market Quotes
 
Non Binding Third-Party Valuation
 
5.31

 
60.55

 
36.19

Agency interest only residential mortgage-backed securities
 
1,225

 
Market Quotes
 
Non Binding Third-Party Valuation
 
10.14

 
18.21

 
15.25

Private label residential mortgage-backed securities
 
60,427

 
Discounted Cash Flows
 
Yield
 
0.5
%
 
26.5
%
 
9.8
%
 
 

 
 
 
Projected Collateral Prepayments
 
2.1
%
 
84.7
%
 
38.3
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.9
%
 
18.2
%
 
8.6
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
0.3
%
 
31.5
%
 
11.3
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
12.5
%
 
90.2
%
 
41.8
%
 
 
 
 
 
 
 
 

 

 
100.0
%
Private label commercial mortgage-backed securities
 
4,770

 
Discounted Cash Flows
 
Yield
 
4.3
%
 
42.5
%
 
18.6
%
 
 


 
 
 
Projected Collateral Losses
 
1.1
%
 
5.2
%
 
2.5
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
2.8
%
 
17.1
%
 
8.5
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
80.1
%
 
96.1
%
 
89.0
%
 
 
 
 
 
 
 
 


 


 
100.0
%
Corporate debt and non-exchange traded corporate equity
 
20,301

 
Discounted Cash Flows
 
Yield
 
3.0
%
 
16.1
%
 
10.6
%
Collateralized loan obligations
 
14,623

 
Discounted Cash Flows
 
Yield
 
7.1
%
 
62.2
%
 
15.2
%
 
 


 
 
 
Projected Collateral Prepayments
 
22.5
%
 
92.9
%
 
77.9
%
 
 
 
 
 
 
Projected Collateral Losses
 
1.9
%
 
40.2
%
 
10.3
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
3.4
%
 
37.2
%
 
9.5
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
%
 
4.1
%
 
2.3
%
 
 
 
 
 
 
 
 


 


 
100.0
%
Consumer loans and asset-backed securities backed by consumer loans
 
135,258

 
Discounted Cash Flows
 
Yield
 
7.0
%
 
18.9
%
 
9.5
%
 
 

 
 
 
Projected Collateral Prepayments
 
2.2
%
 
50.1
%
 
33.5
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.4
%
 
28.6
%
 
8.2
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
46.8
%
 
95.2
%
 
58.3
%
 
 
 
 
 
 
 
 


 


 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 


 
 

 
 
 
 
 


 


 


 
 
 
 
 
 
 
 
 
 
 
 
 
(continued)
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Performing commercial mortgage loans
 
$
84,377

 
Discounted Cash Flows
 
Yield
 
8.0
%
 
15.4
%
 
10.7
%
Non-performing commercial mortgage loans and commercial real estate owned
 
49,610

 
Discounted Cash Flows
 
Yield
 
11.4
%
 
36.5
%
 
17.7
%
 
 

 
 
 
Months to Resolution
 
4.0

 
17.0

 
9.5

Performing residential mortgage loans
 
42,030

 
Discounted Cash Flows
 
Yield
 
1.6
%
 
18.8
%
 
6.2
%
Securitized residential mortgage loans(1)
 
132,424

 
Discounted Cash Flows
 
Yield
 
3.5
%
 
3.5
%
 
3.5
%
Non-performing residential mortgage loans and residential real estate owned
 
8,609

 
Discounted Cash Flows
 
Yield
 
2.8
%
 
34.5
%
 
8.9
%
 
 
 
 
 
 
Months to Resolution(2)
 
1.9

 
40.5

 
25.6

Credit default swaps on asset-backed securities
 
3,140

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
19.8
%
 
26.5
%
 
22.4
%
 
 
 
 
 
 
Projected Collateral Losses
 
14.6
%
 
23.8
%
 
19.7
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
5.8
%
 
14.3
%
 
10.6
%
 
 


 
 
 
Projected Collateral Scheduled Amortization
 
45.5
%
 
51.0
%
 
47.3
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Agency interest only residential mortgage-backed securities
 
4,948

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(3)
 
381

 
3,521

 
730

 
 
 
 
 
 
Projected Collateral Prepayments
 
51.2
%
 
100.0
%
 
69.1
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
48.8
%
 
30.9
%
 
 

 
 
 
 
 
 
 


 
100.0
%
Non-exchange traded common equity investment in mortgage-related entity
 
2,814

 
Enterprise Value
 
Equity Price-to-Book(4)
 
2.0x
 
2.0x
 
2.0x
Non-exchange traded preferred equity investment in mortgage-related entity
 
20,774

 
Enterprise Value
 
Equity Price-to-Book(4)
 
0.9x
 
0.9x
 
0.9x
Non-controlling equity interest in limited liability company
 
5,033

 
Market Quotes
 
Non Binding Third-Party Valuation of the Underlying Assets(5)
 
$
96.91

 
$
96.91

 
$
96.91

Non-controlling equity interest in limited liability company
 
5,693

 
Discounted Cash Flows
 
Yield(5)
 
9.1%
 
9.1%
 
9.1%
Other secured borrowings, at fair value(1)
 
(125,105
)
 
Discounted Cash Flows
 
Yield
 
2.8%
 
2.8%
 
2.8%
(1)
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of March 31, 2018:
 
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
 
$
49,982

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
3.50

 
$
172.00

 
$
80.46

Collateralized loan obligations
 
21,352

 
Market Quotes
 
Non Binding Third-Party Valuation
 
85.00

 
425.00

 
120.95

Corporate debt and non-exchange traded corporate equity
 
6,934

 
Market Quotes
 
Non Binding Third-Party Valuation
 
8.88

 
112.50

 
85.34

Private label commercial mortgage-backed securities
 
9,886

 
Market Quotes
 
Non Binding Third-Party Valuation
 
5.00

 
95.23

 
76.78

Agency interest only residential mortgage-backed securities
 
1,623

 
Market Quotes
 
Non Binding Third-Party Valuation
 
2.70

 
17.17

 
10.94

Private label residential mortgage-backed securities
 
61,880

 
Discounted Cash Flows
 
Yield
 
3.3
%
 
31.7
%
 
9.9
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
1.7
%
 
86.8
%
 
45.9
%
 
 
 
 
 
 
Projected Collateral Losses
 
1.4
%
 
17.6
%
 
9.2
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
0.0
%
 
14.0
%
 
6.6
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
10.8
%
 
90.5
%
 
38.3
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
 
3,823

 
Discounted Cash Flows
 
Yield
 
5.0
%
 
40.7
%
 
17.9
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
39.2
%
 
14.9
%
 
 
 
 
 
 
Projected Collateral Losses
 
1.2
%
 
8.7
%
 
4.2
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
3.3
%
 
10.7
%
 
7.5
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
41.4
%
 
95.5
%
 
73.4
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Corporate debt and non-exchange traded corporate equity
 
14,174

 
Discounted Cash Flows
 
Yield
 
3.0
%
 
14.0
%
 
7.8
%
(continued)
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Collateralized loan obligations
 
$
6,127

 
Discounted Cash Flows
 
Yield
 
7.6
%
 
90.5
%
 
26.4
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
22.2
%
 
94.6
%
 
70.4
%
 
 
 
 
 
 
Projected Collateral Losses
 
1.5
%
 
40.9
%
 
15.4
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
2.6
%
 
36.9
%
 
12.6
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
%
 
4.1
%
 
1.6
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Consumer loans and asset-backed securities backed by consumer loans
 
148,422

 
Discounted Cash Flows
 
Yield
 
7.0
%
 
19.7
%
 
9.4
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
47.1
%
 
34.9
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.2
%
 
42.5
%
 
8.6
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
48.9
%
 
99.8
%
 
56.5
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Performing commercial mortgage loans
 
85,004

 
Discounted Cash Flows
 
Yield
 
8.0
%
 
16.3
%
 
10.8
%
Non-performing commercial mortgage loans and commercial real estate owned
 
52,530

 
Discounted Cash Flows
 
Yield
 
12.6
%
 
19.8
%
 
15.4
%
 
 
 
 
 
 
Months to Resolution
 
5.0

 
14.0

 
8.3

Performing residential mortgage loans
 
107,791

 
Discounted Cash Flows
 
Yield
 
1.2
%
 
14.6
%
 
5.8
%
Securitized residential mortgage loans(1)
 
120,332

 
Discounted Cash Flows
 
Yield
 
4.0
%
 
4.0
%
 
4.0
%
Non-performing residential mortgage loans and residential real estate owned
 
13,528

 
Discounted Cash Flows
 
Yield
 
3.3
%
 
26.3
%
 
9.7
%
 
 
 
 
 
 
Months to Resolution(2)
 
1.0

 
52.3

 
29.6

Credit default swaps on asset-backed securities
 
3,069

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
19.6
%
 
27.5
%
 
22.7
%
 
 
 
 
 
 
Projected Collateral Losses
 
13.4
%
 
24.7
%
 
19.2
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
4.8
%
 
15.6
%
 
10.4
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
44.7
%
 
52.2
%
 
47.7
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Agency interest only residential mortgage-backed securities
 
4,505

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(3)
 
267

 
3,521

 
610

 
 
 
 
 
 
Projected Collateral Prepayments
 
48.6
%
 
100.0
%
 
64.4
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
51.4
%
 
35.6
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded common equity investment in mortgage-related entity
 
2,814

 
Enterprise Value
 
Equity Price-to-Book(4)
 
1.9x
 
1.9x
 
1.9x
Non-exchange traded preferred equity investment in mortgage-related entity
 
27,401

 
Enterprise Value
 
Equity Price-to-Book(4)
 
1.0x
 
1.0x
 
1.0x
Non-controlling equity interest in limited liability company
 
9,806

 
Market Quotes
 
Non Binding Third-Party Valuation of the Underlying Assets(5)
 
$
85.00

 
$
97.47

 
$
91.44

Non-controlling equity interest in limited liability company
 
7,740

 
Discounted Cash Flows
 
Yield(5)
 
9.4%
 
12.6%
 
10.1%
Other secured borrowings, at fair value(1)
 
(113,775
)
 
Discounted Cash Flows
 
Yield
 
3.6%
 
3.6%
 
3.6%

(1)
Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFE as discussed in Note 2.
(2)
Excludes certain loans that are re-performing.
(3)
Shown in basis points.
(4)
Represent an estimation of where market participants might value an enterprise on a price-to-book basis.
(5)
Represents the significant unobservable inputs used to fair value the financial instruments of the limited liability company. The fair value of such financial instruments is the largest component of the valuation of the limited liability company as a whole.
Fair Value Measurement Using Significant Unobservable Inputs
The tables below include a roll-forward of the Company's financial instruments for the three month periods ended March 31, 2018 and 2017 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.
Level 3—Fair Value Measurement Using Significant Unobservable Inputs:
Three Month Period Ended March 31, 2018
(In thousands)
Ending
Balance as of 
December 31, 2017
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
March 31, 2018
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
6,173

 
$
(600
)
 
$
39

 
$
264

 
$
1,101

 
$
(388
)
 
$

 
$
(461
)
 
$
6,128

Private label residential mortgage-backed securities
101,297

 
106

 
2,288

 
293

 
20,660

 
(21,574
)
 
11,561

 
(2,769
)
 
111,862

Private label commercial mortgage-backed securities
12,347

 
(183
)
 
1,554

 
121

 
9,624

 
(7,366
)
 

 
(2,388
)
 
13,709

Commercial mortgage loans
108,301

 
618

 
330

 
(161
)
 
3,988

 
(3,782
)
 

 

 
109,294

Residential mortgage loans
182,472

 
(715
)
 
(54
)
 
(653
)
 
73,040

 
(13,309
)
 

 

 
240,781

Collateralized loan obligations
24,911

 
455

 
2

 
226

 
10,095

 
(8,210
)
 

 

 
27,479

Consumer loans and asset-backed securities backed by consumer loans
135,258

 
(5,896
)
 
501

 
3,804

 
42,133

 
(27,378
)
 

 

 
148,422

Corporate debt
23,947

 
(114
)
 
52

 
364

 
456

 
(6,705
)
 

 

 
18,000

Real estate owned
26,277

 

 
(456
)
 
615

 
4,098

 
(1,424
)
 

 

 
29,110

Corporate equity investments
37,465

 

 

 
4,326

 
9,078

 

 

 

 
50,869

Total investments, at fair value
658,448

 
(6,329
)
 
4,256

 
9,199

 
174,273

 
(90,136
)
 
11,561

 
(5,618
)
 
755,654

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
3,140

 

 
86

 
(71
)
 
24

 
(110
)
 

 

 
3,069

Total financial derivatives– assets, at fair value
3,140

 

 
86

 
(71
)
 
24

 
(110
)
 

 

 
3,069

Total investments and financial derivatives–assets, at fair value
$
661,588

 
$
(6,329
)
 
$
4,342

 
$
9,128

 
$
174,297

 
$
(90,246
)
 
$
11,561

 
$
(5,618
)
 
$
758,723

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other secured borrowings, at fair value
$
(125,105
)
 
$

 
$

 
$
784

 
$
10,546

 
$

 
$

 
$

 
$
(113,775
)
Total other secured borrowings, at fair value
$
(125,105
)
 
$

 
$

 
$
784

 
$
10,546

 
$

 
$

 
$

 
$
(113,775
)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at March 31, 2018, as well as Level 3 financial instruments disposed of by the Company during the three month period ended March 31, 2018. For Level 3 financial instruments held by the Company at March 31, 2018, change in net unrealized gain (loss) of $8.6 million, $(0.1) million, and $0.8 million, for the three month period ended March 31, 2018 relate to investments, financial derivatives–assets, and other secured borrowings, at fair value, respectively.
As of June 30, 2017, the Company modified its procedures to determine the level within the hierarchy for certain financial instruments. Under the revised procedures, the Company examines financial instruments individually rather than in cohorts of like instruments as it had previously. As of March 31, 2018, the Company transferred $5.6 million of securities from Level 3 to Level 2 and $11.6 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.
Three Month Period Ended March 31, 2017
(In thousands)
Ending
Balance as of 
December 31, 2016
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in
Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
March 31, 2017
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
29,622

 
$
(2,592
)
 
$
(35
)
 
$
228

 
$
2,202

 
$

 
$

 
$

 
$
29,425

Private label residential mortgage-backed securities
90,083

 
1,478

 
(703
)
 
2,893

 
8,049

 
(19,527
)
 
3,473

 
(5,414
)
 
80,332

Private label commercial mortgage-backed securities
43,268

 
356

 
342

 
1,411

 

 
(4,077
)
 

 

 
41,300

Commercial mortgage loans
61,129

 
530

 
337

 
1,206

 
23,045

 
(23,739
)
 

 

 
62,508

Residential mortgage loans
84,290

 
140

 
(51
)
 
404

 
34,138

 
(6,271
)
 

 

 
112,650

Collateralized loan obligations
44,956

 
(1,183
)
 
920

 
2,532

 
38,712

 
(15,376
)
 

 

 
70,561

Consumer loans and asset-backed securities backed by consumer loans(1)
107,157

 
(3,057
)
 
(552
)
 
837

 
24,418

 
(20,961
)
 

 

 
107,842

Corporate debt
25,004

 
100

 
331

 
158

 
47,094

 
(13,078
)
 

 

 
59,609

Real estate owned
3,349

 

 
60

 
106

 
24,157

 
(2,282
)
 

 

 
25,390

Corporate equity investments(1)
29,392

 

 

 
271

 
5,000

 
(746
)
 

 

 
33,917

Total investments, at fair value
518,250

 
(4,228
)
 
649

 
10,046

 
206,815

 
(106,057
)
 
3,473

 
(5,414
)
 
623,534

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
5,326

 

 
37

 
502

 
59

 
(96
)
 

 

 
5,828

Total return swaps
155

 

 
157

 
(155
)
 

 
(157
)
 

 

 

Warrants
106

 

 
(100
)
 
(6
)
 

 

 

 

 

Total financial derivatives– assets, at fair value
5,587

 

 
94

 
341

 
59

 
(253
)
 

 

 
5,828

Total investments and financial derivatives–assets, at fair value
$
523,837

 
$
(4,228
)
 
$
743

 
$
10,387

 
$
206,874

 
$
(106,310
)
 
$
3,473

 
$
(5,414
)
 
$
629,362

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives– liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(256
)
 
$

 
$
(446
)
 
$
466

 
$
18

 
$

 
$

 
$

 
$
(218
)
Total return swaps
(249
)
 

 
(206
)
 
248

 
283

 
(76
)
 

 

 

Total financial derivatives– liabilities, at fair value
$
(505
)
 
$

 
$
(652
)
 
$
714

 
$
301

 
$
(76
)
 
$

 
$

 
$
(218
)

(1)
Conformed to current period presentation.
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at March 31, 2017, as well as Level 3 financial instruments disposed of by the Company during the three month period ended March 31, 2017. For Level 3 financial instruments held by the Company at March 31, 2017, change in net unrealized gain (loss) of $6.9 million, $0.5 million, and $0.5 million, for the three month period ended March 31, 2017 relate to investments, financial derivatives–assets, and financial derivatives–liabilities, respectively.
As of March 31, 2017, the Company transferred $5.4 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view.
In addition, as of March 31, 2017, the Company transferred $3.5 million of non-Agency RMBS from Level 2 to Level 3. Since December 31, 2016, these securities exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities.
There were no transfers of financial instruments between Level 1 and Level 2 during the three month periods ended March 31, 2018 and 2017.